The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy
暫譯: 微生物組與癌症治療:克服抗藥性並提升療效
Aggarwal, Sadhna, Malik, Garima, Singh, Arun Kumar
- 出版商: Academic Press
- 出版日期: 2026-09-11
- 售價: $6,880
- 貴賓價: 9.5 折 $6,536
- 語言: 英文
- 頁數: 414
- 裝訂: Quality Paper - also called trade paper
- ISBN: 0443332061
- ISBN-13: 9780443332067
海外代購書籍(需單獨結帳)
相關主題
商品描述
The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy delves into the intricate relationship between the microbiome and cancer treatment, highlighting the microbiome's critical role in drug resistance and therapeutic efficacy. The book's chapters are meticulously organized to provide a deep understanding of how the microbiome interacts with the immune system and influences cancer development and response to therapies. This book opens new avenues for investigation by providing a better understanding of the mechanisms of resistance and the role of microbiome alterations in chemoresistance. Sections also address the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters foster interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. Readers will benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.
商品描述(中文翻譯)
《微生物群系與癌症治療:克服抗藥性並提升療效》深入探討微生物群系(microbiome)與癌症治療之間錯綜複雜的關係,凸顯微生物群系在藥物抗性與治療療效中所扮演的關鍵角色。本書各章經過精心編排,旨在深入理解微生物群系如何與免疫系統互動,以及如何影響癌症的發展與對治療的反應。本書透過增進讀者對抗藥性機制,以及微生物群系變化在化學治療抗藥性(chemoresistance)中所扮演角色的理解,為相關研究開啟新的方向。
各章也探討微生物群系變化與化學治療抗藥性之間複雜的「先有雞還是先有蛋」關係。內容涵蓋多元主題,促進免疫學、微生物學、腫瘤學與藥理學等領域之間的跨學科合作,推動以整體性方法進行癌症治療。讀者將藉此了解並更加掌握微生物群系如何影響健康,尤其是在癌症情境下的影響,進而做出更明智的健康選擇。